Want to see SCND full AI Analyst Report?
Scientific Industries (SCND) Risk Analysis
Risk Overview Q1, 2022
Source: the company's latest filing for the period ended Mar 31, 2022, filed May 16, 2022
Risk Change Over Time
No filing history is available.
- Corporate Activity and Growth - Risk 1Integration - The Company May Face Challenges with Integrating Acquisitions and Achieving the Financial and Other Results Anticipated at the Time of Acquisition
The Company may face challenges integrating its recent acquisition of Aquila or future acquisitions with its existing operations. These challenges could include difficulty in integrating or consolidating business processes and systems and challenges with integrating the business cultures, especially since Aquila is located in Germany. In addition, the process of integrating operations could result in an interruption of normal business operations.
Risk Highlights Q1, 2022
Risk Word Cloud
Risk Factors Full Breakdown - Total Risks 12
- Share Price & Shareholder Rights - Risk 1The Common Stock of the Company is Thinly Traded and is Subject to Volatility
As of October 8, 2021, there were 6,458,143 shares of Common Stock of the Company outstanding, of which 3,820,130 (59%) were held by affiliates or Directors and Officers of the Company. The Common Stock of the Company is traded on the Over-the-Counter Bulletin Board and, historically, has been thinly traded. There have been a number of trading days during fiscal 2021 on which no trades of the Company's Common Stock were reported. Accordingly, the market price for the Common Stock is subject to great volatility.
See a full breakdown of risk according to category and subcategory. The list starts with the category with the most risk. Click on subcategories to read relevant extracts from the most recent report.